Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 15.81% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | 15.81% | |
| Cost of Revenue | -- | -- | -- | 16.81% | |
| Gross Profit | -- | -- | -- | 13.55% | |
| SG&A Expenses | -- | -- | -- | 13.96% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -114.67% | |
| Total Operating Expenses | -- | -- | -- | 15.80% | |
| Operating Income | -- | -- | -- | 16.17% | |
| Income Before Tax | -- | -- | -- | 18.40% | |
| Income Tax Expenses | -- | -- | -- | 47.67% | |
| Earnings from Continuing Operations | -- | -- | -- | 2.01% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -- | 2.01% | |
| EBIT | -- | -- | -- | 16.17% | |
| EBITDA | -- | -- | -- | 8.56% | |
| EPS Basic | -- | -- | -- | 1.85% | |
| Normalized Basic EPS | -- | -- | -- | 19.62% | |
| EPS Diluted | -- | -- | -- | 1.85% | |
| Normalized Diluted EPS | -- | -- | -- | 19.62% | |
| Average Basic Shares Outstanding | -- | -- | -- | -0.05% | |
| Average Diluted Shares Outstanding | -- | -- | -- | -0.05% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |